Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Pharmacology and Experimental Therapeutics|October 24, 2023
Pantothenate Kinase Activation Restores Brain Coenzyme A in a Mouse Model of Pantothenate Kinase-Associated NeurodegenerationChitra Subramanian, Matthew W Frank, Rajaa Sukhun, et al.Nature Communications|April 13, 2019
Dynamic anticipation by Cdk2/Cyclin A-bound p27 mediates signal integration in cell cycle regulationMaksym Tsytlonok, Hugo Sanabria, Yuefeng Wang, et al.Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
Stereoselective synthesis of 3-hydroxymethyl-D-cyclopentenone, the versatile intermediate for the synthesis of carbocyclic nucleosidesWon Jun Choi, Hyung Ryong Moon, Hea Ok Kim, et al.Journal of Medicinal Chemistry|August 18, 2021
X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization InhibitorSouvik Banerjee, Foyez Mahmud, Shanshan Deng, et al.Angewandte Chemie (International Ed. in English)|October 6, 2021
Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACsJaeki Min, Anand Mayasundari, Fatemeh Keramatnia, et al.Iscience|January 25, 2021
17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcomaShivendra Singh, Ahmed Abu-Zaid, Wenwei Lin, et al.Cancer Research|July 12, 2020
Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP Jake Slavish, Liying Chi, Mi-Kyung Yun, et al.Science Translational Medicine|July 20, 2022
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcomaShivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, et al.Pageof 4